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CD8 T cell responses rapidly select viral variants during acute human immunodeficiency virus (HIV)/simian immunodefi-
ciency virus (SIV) infection. We used pyrosequencing to examine variation within three SIV-derived epitopes (Gag386-394GW9,
Nef103-111RM9, and Rev59-68SP10) targeted by immunodominant CD8 T cell responses in acutely infectedMauritian cynomol-
gus macaques. In animals recognizing all three epitopes, variation within Rev59-68SP10 was associated with delayed accumula-
tion of variants in Gag386-394GW9 but had no effect on variation within Nef103-111RM9. This demonstrates that the entire T cell
repertoire, rather than a single T cell population, influences the timing of immune escape, thereby providing the first example of
conditional CD8 T cell escape in HIV/SIV infection.
Escape from CD8 T cell responses is a hallmark of humanimmunodeficiency virus (HIV)/simian immunodeficiency vi-
rus (SIV) infection (6, 16, 24). Within days of the first detectable
CD8 T cell responses in blood, viral variants that abrogate bind-
ing to major histocompatibility complex class I (MHC class I)
molecules, impair T cell receptor recognition, or diminish the
efficiency of epitope processing begin to emerge (reviewed in ref-
erences 15 and 29). In SIV-infectedmacaques, where the timing of
infection is known, recognizable CD8 T cell epitopes can be
largely lost by 17 days postinfection in replicating viruses isolated
from plasma (2, 11) and potentially even earlier in lymph nodes
(26). Such responses are thought to be highly potent but of mar-
ginal protective value because they are short-lived.
In studies of CD8 T cell escape during acute HIV/SIV infec-
tion, some individuals exhibit markedly less epitope variation
than others, despite the presence of detectable CD8 T cell re-
sponses (7, 20, 22). It has been proposed that delayed immune
escape is a consequence of the CD8 T cell immunodominance
hierarchy, a characteristic of immunity that is influenced by an
individual’s set of MHC class I alleles (1, 13, 19, 21, 27). An alter-
nate hypothesis for explaining the differential timing of immune
escape is that the HIV/SIV genome can tolerate only a limited
amount of simultaneous variation, such that variants accumulate
in epitopes sequentially. Pyrosequencing has enabled investiga-
tors to quantify genome-wide variation within CD8 T cell
epitopes and explore the progression of immune escape with un-
precedented resolution (2, 3, 11, 26). Using this approach, we
tested the hypothesis that there is an upper limit to the number of
SIV genomic sites in which simultaneous variation can be toler-
ated, such that escapewithin a given epitopemay be delayed by the
selection of variants in another epitope.
We studied a cohort of 18MHC class I definedMauritian cyn-
omolgus macaques (MCM) infected intrarectally with 7,000 50%
tissue culture infectious dose (TCID50) pathogenic SIVmac239
viruses. MCM have limited MHC genetic diversity, such that
nearly all of their MHC alleles can be explained by seven common
haplotypes, termedM1 toM7 (9, 23). SixMCMwere homozygous
for theM1MHChaplotype (CY0320 toCY0325), six wereM1/M3
heterozygotes (CY0326 to CY0331), and six were M3 homozy-
gotes (CY0332 to CY0337). Both haplotypes carry Mafa-A1*063,
an allele that restricts two epitopes (Gag386-394GW9 and
Nef103-111RM9) targeted by acute-phase immunodominant
CD8T cell responses (2, 8). TheM3 haplotype also carriesMafa-
B*075, an allele that restricts a strong acute-phase CD8 T cell
response directed against Rev59-68SP10 (8).
Wemeasured CD8 T cell responses against all three epitopes in
cells from bronchoalveolar lavage (BAL) fluid and peripheral blood
samples using MHC-peptide tetramers during acute infection.
Strong responses against Nef103-111RM9 and Gag386-394GW9 were
detected in BAL fluid samples of all 18 animals (Fig. 1A; see also
supplemental Table 1 at go.wisc.edu/44305k/). Rev59-68SP10 re-
sponses were detected in M3 animals, but their magnitude was
more modest than that of the responses targeting the other two
epitopes. Responses in BAL fluid samples were more robust than
those in the blood samples (Fig. 1B and Table S1), consistent with
earlier studies of SIV-specific CD8 T cell responses at this mucosal
site (17).
At 3 weeks postinfection, we explored all three epitope-
specific immune responses in the peripheral blood samples by a
gamma interferon (IFN-) enzyme-linked immunosorbent
spot (ELISPOT) assay. Although there are limitations to this as-
say, it can be used as a proxy for T cell functionality (25, 28). We
found that the frequencies of IFN--secreting T cells specific for
Nef103-111RM9 and Gag386-394GW9 were similar among all three
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FIG 1 Acute immunodominant CD8 T cell responses in cells isolated from BAL fluid and peripheral blood samples. (A)MHC-peptide tetramers representing
three SIVmac239-derived epitopes (Nef103-111RM9, Gag386-394GW9, and Rev59-68SP10) were used to quantify the percentages of antigen-specific CD3CD8 T
cells in BAL fluid samples at 0, 2, 3, and 4 weeks after SIVmac239 infection. (B) The same tetramers were used to quantify the percentages of antigen-specific
CD3 CD8 T cells at 0, 1.5, 2, 3, 4, and 6 weeks after infection in peripheral blood samples. For panels A and B, six animals with each MHC genotype were
followed:M1/M1MCMs (black),M1/M3MCMs (orange), andM3/M3MCM(blue). Each shape represents a different animal. (C) T cell responses targeting the
three SIV-derived peptide epitopes were measured by an IFN- ELISPOT assay 3 weeks after SIVmac239 infection. The average numbers of spot-forming
colonies (SFCs) per 106 PBMC and the standard errors are shown. Six animals with each MHC genotype are shown as indicated in the legend.
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groups (Fig. 1C). Responses targeting Rev59-68SP10were robust in
M3MCM but absent in M1/M1 MCM. This assay suggests that
the presence of peripheral IFN--secreting T cells specific for
Rev59-68SP10 did not curb the frequency of IFN--secreting T cells
specific for Gag386-394GW9 or Nef103-111RM9.
To examine the kinetics of CD8 T cell selection, we isolated
and pyrosequenced plasma virus from the SIVmac239 inoculum
and all 18 animals at 4 weeks postinfection, using methods de-
scribed previously (3). Briefly, four overlapping reverse
transcription-PCR (RT-PCR) amplicons spanning all SIV genes
were generated and purified. Amplicons were fragmented with a
NexteraDNA sample prep kit (Epicentre,Madison,WI), and then
multiplex identifier (MID) tags and adapter sequences for Roche/
454 pyrosequencing were added. Purified fragments were pyrose-
quenced using a Roche/454 GS Junior. We obtained an average of
46,889 reads per genome, with an average coverage of 1,126 reads
FIG 2 Amino acid variation within three epitope sequences at 4 weeks after SIVmac239 infection. (A) The SIVmac239 inoculum was subjected to full-genome
Roche/454 pyrosequencing. No significant variation was detected in the three epitope sequences Nef103-111RM9, Rev59-68SP10, and Gag386-394GW9 in the
SIVmac239 inoculum. Variants were included in the table if they were also present in panel B, C, or D. (B, C, and D) Viruses replicating in the plasma samples
of all 18 animals 4 weeks after SIVmac239 infection were subjected to full-genome Roche/454 pyrosequencing. Amino acid variants in the three epitopes
Nef103-111RM9, Rev59-68SP10, andGag386-394GW9 inM1/M1 animals (black),M1/M3 animals (orange), andM3/M3 animals (blue) were interrogated. Sequence
variation is shown for Nef103-111RM9 (B), Rev59-68SP10 (C), and Gag386-394GW9 (D). The wild-type sequence is shown at the top of each table. Masked identical
bases are shown with a dot, and amino acid replacements are shown with a capital letter. The frequency of a given epitope variant sequence is shown. A variant
sequence had to be present in at least one animal at a frequency of 5% or greater to be included in the table. The legend indicates the color associated with a given
variant frequency. A “0” indicates that no reads were detected with that sequence.
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at each position (see supplemental Table 2 at go.wisc.edu/4430sk/).
In viral populations from all animals except CY0330, the theoret-
ical number of templates was greater than the average coverage,
thus alleviating concerns about resampling.
Amino acid variation within the three CD8 T cell epitopes
was examined using a custom data analysis pipeline (see sup-
plemental Fig. 1 at go.wisc.edu/4430sk/) in Galaxy, an open-
source system for processing next-generation sequence data (4,
5, 14). Sequence reads were translated in all six reading frames
and aligned against SIVmac239 using BLAT (BLAST-Like
Alignment Tool) (18). Reads containing low-quality bases
within epitopes were discarded. The inoculum showed no sub-
stantial variation at any of the three epitopes (Fig. 2A). As
expected, Nef103-111RM9 rapidly accumulated sequence varia-
tion in viruses from all 18 animals (Fig. 2B) (2). The wild-type
sequence comprised a mean of 1.7% in all animals, with only
one animal having more than 10% wild-type virus (CY0329).
The majority of epitope sequences in Rev59-68SP10 were vari-
antin 11 of 12 M3 MCM (Fig. 2C), but negligible variation
was observed in M1/M1 MCM.
In contrast to the widespread sequence variation detected in
Nef103-111RM9 and Rev59-68SP10, sequence variation within
Gag386-394GW9 was largely restricted to M1/M1 MCM (10) (Fig.
2D). All 18 animals possessed two copies of the restrictingMafa-
A1*063 allele, which is carried on both the M1 and the M3 haplo-
types. Extensive variation within Gag386-394GW9 was observed in
all 6M1/M1MCMbut only 2 of the 12M3 animals. On average,
83.34%of readswerewild type inM3MCM,while only 6.64%of
reads were wild type in M1/M1 MCM. Virus isolated from an
M1/M3 (CY0328) animal and an M3/M3 (CY0336) animal had
high frequencies of nonsynonymous substitutions (23.1% and
82.5%, respectively) at the arginine codon immediately upstream
of the epitope, but it is unclear whether this mutation affects
epitope presentation. Different variants predominated in each
M1/M1 animal, suggesting that multiple distinct variants can be
tolerated within this epitope.
We sequencedGag386-394GW9 from provirus in genomic DNA
of lymph node cells isolated at 3 weeks postinfection, as a recent
report described that the earliest immune escape variants are pres-
ent at this site (26). Using amplicon-based pyrosequencing (2), we
found that variants in Gag386-394GW9 were detectable in M1/M1
MCM but absent in M3 MCM (see supplemental Fig. 2 at go
.wisc.edu/4430sk/), a pattern consistent with our observations in
the plasma virus at 4 weeks (Fig. 2D).
To determine whether variants eventually accumulate in the
Gag386-394GW9 epitope in M3MCM, we sequenced the plasma
virus in 15 of the animals at 12 weeks postinfection, including
11 M3 MCM. Although viral loads were markedly lower,
Gag386-394GW9 sequenceswere nearly completely variant (range, 96
to 100%) in the M3 animals (see supplemental Fig. 3 at go
.wisc.edu/4430sk/). These results demonstrate that Gag386-394
GW9-specific CD8 T cell responses do eventually select for se-
quence variants in M3 animals.
Given the lack of nonsynonymous substitutions within
Gag386-394GW9 in themajority ofM3 animals at 4weeks postinfec-
tion, we asked whether other sites in the viral genome were accu-
mulating variants.We performed nucleotide alignments using the
LASTZ short read mapper as implemented in Galaxy (see supple-
mental Fig. 4 at go.wisc.edu/4430sk/). Our qualifications for con-
sidering a variant authentic were quite conservative relative to
those in other studies (11, 26); we required that the percentage of
variants was1% and greater than three times the percentage of
N and indel sequences.We applied this strategy to the SIVmac239
inoculum and the viral populations replicating in all 18 animals at
4 weeks postinfection (Fig. 3). We detected low-frequency vari-
ants in the inoculum (see supplemental Table 3 at go.wisc.edu
/4430sk/), but this was not entirely unexpected, as it was passaged
for 5 days on rhesus macaque peripheral bloodmononuclear cells
(PBMC). Variants at the same positions in the sequences from the
18 animals were relatively rare (Table S4). Across the 18 viral
genomes, we detected 659 variants, including 82 nonsynonymous
mutations at a frequency of 10% or greater (Table S5). Of these
high-frequency variants, 66% were located within the three im-
munodominant CD8 T cell epitopes described above.
In this study, we show that accumulation of sequence variants
in CD8 T cell epitopes during the acute phase is predictable and
reproducible when both viral and host genetics are controlled, but
this is not the case among animals sharing only a singleMHC class
I allele. We provide evidence that acquisition of sequence variants
FIG 3 Limited genome-wide nucleotide variation at 4 weeks after SIVmac239
infection. The percent variation at each nucleotide position (from site 1300 to
site 10200) is shown for the inoculum, six M1/M1MCM (CY0320 to CY0325;
black), six M1/M3MCM (CY0326 to CY0331; orange), and six M3/M3MCM
(CY0332 to CY0337; blue). Each symbol shape represents a different
animal. Nonsynonymous mutations are shown as filled characters, and
synonymous mutations are shown as open characters. The nucleotide po-
sitions corresponding to the N and C termini of Gag386-394GW9,
Rev59-68SP10, andNef103-111RM9are shownasdashed vertical lines.Only variants
present at a frequency of 1%or greater are shown. For an alternate visualization
of these data with the Layercake visualization tool (12), please go to
http://goo.gl/6uaDY.
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within one epitope targeted by a shared CD8 T cell response is
delayed when an additional discrete CD8 T cell response is pres-
ent. We found that the accumulation of variants in Rev59-68SP10
preceded the development of variation in Gag386-394GW9 when
CD8 T cell responses targeting both epitopes were present. One
explanation for this “conditional” CD8 T cell escape during
acute SIV infection is that there is a limited amount of simultane-
ous variation tolerated by the HIV/SIV genome. Alternately, it is
possible that variants in Rev59-68SP10 are simply tolerated bet-
ter than those in Gag386-394GW9, and therefore variants in
Rev59-68SP10 accumulatemore rapidly when CD8 T cell responses
targeting both epitopes are present. Nonetheless, these data sug-
gest that variants generally accumulate in a finite number of
epitopes immediately after CD8 T cell responses emerge, even
when there are additional CD8 T cell responses present that also
have the potential to rapidly select escape variants.
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